Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members?
By K. Wolk, S. Kunz, K. Asadullah, R. Sabat. Journal of Immunology, 2002
619 citations recorded by the source corpus.
Subfields: Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/dca2c12fbe2a55ae5442423baabf781026bc9d87
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
- V. Kuchroo
- T. Korn
- M. Oukka
- R. Flavell
- M. Collins
- M. V. D. van den Brink
- A. Di Cesare
- Frank O. Nestle
In Oncology
Citations in the corpus
- Interleukin-10 Therapy—Review of a New Approach (2003, background): “This data suggests that immune cells are a major source of the new IL-10 family members (Wolk et al., 2002).”
- IL-22 increases the innate immunity of tissues. (2004, methodology): “Assessment of composition of isolated cell populations and confir- Western Blot Analysis mation of cellular activation were performed by flow cytometry as Cell lysing, protein electrophoresis, and Western blotting was perpreviously described (Wolk et al., 2002).”
- Fish Cytokines and Immune Response (2012, background): “It contained a homologue of IL-22/26, that later studies of the ze‐ brafish genome revealed to be two genes, one with clear homology to IL-22 and one with somewhat less clear homology to IL-26 [216].”
- Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease (2008, background): “Previous work has shown that activation by IL-12 and IL-18 induces IL-22 in a heterogenous NK cell population (Wolk et al., 2002).”
- Interleukin-22: immunobiology and pathology (2015, background): “One of the first cellular sources of IL-22 to be characterized were a subset of NK cells (29) that were designated NK22 cells (70, 71).”
- Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides (2006, background): “IL-22 was initially characterized as a Th1 cytokine because IL-12 treatment of T cells up-regulates IL-22 mRNA (17).”
- IL-17 and Th17 Cells. (2009, background): “However, IL-22 is not exclusively produced by Th17 cells, but rather appears to be produced by activated T cells in general, as well as by IL-2- or IL-12-stimulated natural killer (NK) cells (36).”